As of 3:59pm ET
| +0.04 / +0.48%|
The 8 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 9.50, with a high estimate of 17.00 and a low estimate of 4.00. The median estimate represents a +14.60% increase from the last price of 8.29.
The current consensus among 8 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.